SMYD3 Antibody
Selleck Chemicals
SKU:F2489-20UL
Couldn't load pickup availability

About the Target
SMYD3 (SET and MYND domain-containing protein 3) is a histone methyltransferase that plays critical roles in transcriptional regulation, chromatin remodeling, and oncogenesis. Structurally, SMYD3 contains a SET domain responsible for its methyltransferase activity and a MYND domain that facilitates protein-protein interactions. It primarily methylates histone H3 at lysine 4 (H3K4) and other histones, such as H2A.
Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following SMYD3 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.
Research Context
SMYD3 is commonly interpreted in the context of cancer, dna damage / repair, and epigenetics research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.
Consider these angles when interpreting target-level changes:
- apparent redistribution between cytoplasm and nucleus across matched conditions
- changes associated with proliferative state, oncogenic signaling, or treatment response
- stress-induced changes after checkpoint activation or genotoxic challenge
- links between target behavior and transcriptional or chromatin-state changes
Variant Considerations
If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for SMYD3. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.
Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in SMYD3 reflect biology rather than handling. When interpreting SMYD3, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.
For multi-run studies, a shared reference condition can keep SMYD3 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.
- Targets:
- SMYD3
- Research Area:
- Cancer • Cell Signaling • DNA Damage / Repair • Epigenetics
- Application:
- FCM • IF • IHC • IP • WB
- Reactivity:
- Human • Mouse • Rat
- Specificity:
- SMYD3 Antibody [F16L17] recognizes endogenous levels of total SMYD3 protein.
- Host:
- Rabbit
- Clonality:
- Monoclonal
- Clone:
- F16L17
- UniProt:
- Q9H7B4
- Storage Buffer:
- PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN₃
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.